GLP-1 Use and Fatigue
ChatGPTMay 26, 2025 Fatigue or low energy is a commonly reported side effect among users of GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), but it is not as well characterized or studied as gastrointestinal effects. Here’s what is currently known: 🔍 What We Know About Fatigue and GLP-1 Use ✅ PrevalenceFatigue is reported […]
Study compares Zepbound and Wegovy for weight loss in direct comparison
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New England Journal of Medicine. Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a […]
Ozempic teeth, face and tongue: Side effects of GLP-1 drugs explained
As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program
Scientists Discover Powerful Anti-Cancer Benefits of Popular Weight Loss Drugs
After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related cancer. New research presented at the European Congress on Obesity (ECO) in Malaga, Spain, and published in the journal eClinicalMedicine, suggests that some widely used weight-loss medications may do more than just help people slim […]
New Data on GLP-1 RAs and Psychiatric Side Effects
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without preexisting mental illness. Medscape Medical News
What are GLP-1 medications?
GLP-1s are drugs that help people manage diabetes and lose weight. Their surging popularity has a range of economic and public health implications.